|
|
The longevity industry’s fastest-growing company does not make anyone live longer. It sells a feeling that the question is being handled. |
|
One Number
The amount that investors just paid, in valuation terms, for every body scan Neko Health has ever performed. Financial Times/ TechCrunch, July 2026 Neko Health — the preventive-scanning company co-founded by Spotify’s Daniel Ek — raised $700 million in July at a valuation the Financial Times put at almost $7 billion. Eighteen months earlier, the same company was worth $1.7 billion. It has performed just over 100,000 scans in its lifetime — roughly $70,000 of valuation for every scan ever done. |
|
|
One Argument The longevity industry's first profitable product is not a longer life. It is the feeling of having done something about a shorter one.Longevity stopped being a fringe science and became a spending category. On the science side, the world's deepest pockets are betting on the biology. Sam Altman backs Retro Biosciences, which is building AI models with OpenAI to design cell-repairing proteins. Saudi Arabia's Hevolution Foundation budgets up to $1 billion a year for aging research. On the consumer side, the money arrived faster — clinics, scans and supplements selling to people who want results now. The science asks for decades. The shop is open and taking bookings. The most heavily funded biotech startup with the longevity focus in history — Altos Labs, launched in 2022 with $3 billion from backers including Jeff Bezos — has yet to bring anything to market. What sells today is a 60-minute appointment with scanners photographing every mole, a blood draw, a full cardiovascular map, and a doctor who walks you through what it means. Neko says more than 350,000 people have joined its waitlist or booked a scan. There are no sick people in that queue. The customer is a healthy, affluent professional who can spare an hour and $499 a visit. When UBS surveyed more than 5,000 wealthy investors back in 2018, 53% expected to live to 100, against a life expectancy of roughly 80 in most developed countries. The entire consumer longevity industry lives in the gap between that expectation and what medicine can currently promise. The valuation is not pricing scans. It is pricing a habit. Just 100,000 lifetime scans cannot support a $7 billion valuation. But 350,000 people returning annually, indefinitely, might. Daniel Ek describes the scanner as “the first iPod” — hardware that improves, falls in cost, and locks in a returning customer. The bet is that checking your body becomes a subscription, like checking your portfolio. Early detection saves specific lives by catching malignant moles unlikely to be otherwise found. The scan bundles tests that cost more when bought separately. However, the key claim — that routinely scanning people without symptoms makes them live longer — has no trial evidence behind it. The Cochrane review (the benchmark for pooled medical trial evidence) of general health checks, covering more than 250,000 participants across 17 trials, found they did not reduce deaths. Screening the healthy produces false alarms and over-diagnosis as reliably as it produces saves.
|
|
One Position Separate the two things a longevity purchase can buy. It can be either detection or extension. The tests with evidence behind them (blood pressure, cholesterol, skin checks) are healthcare. The promise of added years is, at least for now, a luxury good. Treat it as such when making a buying decision. I will change my view when a published academic mortality study shows that people who get scanned outlive comparable people who don’t. Until then, buy the reassurance if it is worth the price to you, but do not treat it as an investment in your lifespan. Have you — or someone you know — paid for a full-body scan or a longevity clinic membership already, and what did you tell yourself the fee was actually buying? |
|
If this was forwarded to you and you'd like to receive Corporate Financier's Notes every Thursday, you can subscribe here. Reading on your phone? Tap the three dots or overflow menu in the top corner of your email app and select View in browser for the best experience.
|